SEC Form 4 · accession 0001209191-17-056091
MAGELLAN HEALTH INC · MGLN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Daniel N Gregoire
Officer — General Counsel and Secretary
Period of report
Oct 3, 2017
Accepted (ET)
Oct 5, 2017 · 12:36 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000019411
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary Common Stock, $0.01 par value | Oct 3, 2017 | X | 5,000 | $63.95 | A | 18,457 | D | |
| Ordinary Common Stock, $0.01 par value | Oct 3, 2017 | S | 5,000 | $88.00 | D | 13,457 | D | |
| Ordinary Common Stock, $0.01 par value | Oct 4, 2017 | X | 7,475 | $63.95 | A | 20,932 | D | |
| Ordinary Common Stock, $0.01 par value | Oct 4, 2017 | S | 5,000 | $88.00 | D | 15,932 | D | |
| Ordinary Common Stock, $0.01 par value | Oct 4, 2017 | S | 2,475 | $88.10 | D | 13,457 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Options (right to buy)F3,F2 | $63.95 | Oct 3, 2017 | X | 5,000 | D | — | Mar 5, 2025 | Common Stock | 5,000 | 32,615 | D |
| Stock Options (right to buy)F3,F2 | $63.95 | Oct 4, 2017 | X | 7,475 | D | — | Mar 5, 2025 | Common Stock | 7,475 | 25,140 | D |
Explanation of responses
- F1This transaction was effectuated pursuant to a Rule 10b-5-1 Plan.
- F2Of the 37,615 stock options granted, 25,077 are currently vested and exercisable. The remainder of 12,538 options shall vest on March 4, 2018.
- F3Not applicable.